Antidepressant Target Dose Optimization and Control of Severe Asthma Exacerbations in Uninsured and Underinsured Patients with Anxiety and/or Depression

A. Shoair, Osama; A. Cook, Elizabeth; Shipman, Denver; L. Dunn, Rebecca

doi:10.1002/phar.2374

Public

Antidepressant Target Dose Optimization and Control of Severe Asthma Exacerbations in Uninsured and Underinsured Patients with Anxiety and/or Depression

Published in Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy • Feb 15, 2020

Authors:

Osama A. Shoair

Elizabeth A. Cook

Denver Shipman

Abstract

BACKGROUND: Generalized anxiety disorder (GAD) and major depressive disorder (MDD) are prevalent in patients with asthma. These disorders may increase asthma severity and decrease asthma control. No studies have evaluated the impact of achieving antidepressant target dose optimization compared with ...

Subject

Medicine

Asthma

Major depressive disorder

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!